Abstract
LATS1/2 loss enhances tumor immunogenicity to promote antitumor immune responses and tumor regression.
- ©2016 American Association for Cancer Research.
LATS1/2 loss enhances tumor immunogenicity to promote antitumor immune responses and tumor regression.